Conservative treatment of superficial transitional cell carcinoma of prostatic urethra with intravesical BCG
- 1 November 1989
- Vol. 34 (5) , 231-237
- https://doi.org/10.1016/0090-4295(89)90314-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Superficial Transitional Cell Carcinoma of the Bladder Associated with Mucosal Involvement of the Prostatic Urethra: Results of Treatment with Intravesical Bacillus Calmette-GuerinJournal of Urology, 1988
- Ureteral Carcinoma in Situ After Successful Intravesical Therapy for Superficial Bladder Tumors: Incidence, Possible Pathogenesis and ManagementJournal of Urology, 1987
- Toxicity of intravesical BCG and its management in patients with superficial bladder tumorsCancer, 1987
- Two Courses of Intravesical Bacillus Calmette-Guerin for Transitional Cell Carcinoma of the BladderJournal of Urology, 1986
- Complications of Bacillus Calmette-Guerin Immunotherapy in 1,278 Patients with Bladder CancerJournal of Urology, 1986
- Prognostic Value of Purified Protein Derivative Skin Test and Granuloma Formation in Patients Treated with Intravesical Bacillus Calmette-GuerinJournal of Urology, 1986
- Long-Term Effect of Intravesical Bacillus Calmette-Guerin on Flat Carcinoma in Situ of the BladderJournal of Urology, 1986
- Durable Response of a Carcinoma in Situ of the Renal Pelvis to Topical Bacillus Calmette-GuerinJournal of Urology, 1985
- Bacillus Calmette-Guerin Immunotherapy for Bladder CancerJournal of Urology, 1985
- Prostatic Involvement by Transitional Cell Carcinoma: Pathogenesis, Patterns and PrognosisJournal of Urology, 1977